Doximity (DOCS) reported fiscal Q1 non-GAAP earnings Thursday of $0.36 per diluted share, up from $0.28 a year earlier.

Analysts polled by FactSet expected $0.30.

Revenue for the quarter ended June 30 was $145.9 million, up from $126.7 million a year earlier.

Analysts surveyed by FactSet expected $139.5 million.

The company expects fiscal Q2 revenue of $157 million to $158 million.

Analysts expect $150.2 million.

The company now expects fiscal 2026 revenue of $628 million to $636 million, up from the previous guidance of $619 million to $631 million.

Analysts surveyed by FactSet expect $626.5 million.

Separately, Doximity said Thursday it acquired Pathway Medical.

The deal closed on July 29 for a cash consideration of $26 million and up to $37 million in additional equity grants, according to the company.

Doximity shares were up nearly 7% in after-hours activity.